乳房切除前放疗与切除后放疗对显微外科乳房重建结局的比较
该研究为随机临床试验的二次分析,比较了乳房切除前放疗(Pre-MRT)后行乳房切除+显微外科即刻乳房重建(IMBR)与乳房切除后放疗(PMRT)后行显微外科延迟乳房重建(DBR)的并发症率和结局。结果显示两组均无完全自体皮瓣丢失,受区其他并发症率相似;PMRT组中放置组织扩张器(TE)者受区感染率为20%(13/66),其中9例(14%)因并发症需取出TE。结论认为Pre-MRT联合IMBR的并发症率与PMRT联合DBR相似,且避免了TE相关并发症并缩短了达到确定性乳房重建的时间。
要点
- Pre-MRT联合IMBR与PMRT联合DBR的受区并发症率相似,均无完全自体皮瓣丢失。
- PMRT组中放置TE者受区感染率为20%(13/66),14%(9/66)因并发症取出TE。
- Pre-MRT联合IMBR可避免TE相关并发症并缩短确定性重建时间。
核心结论
- Pre-MRT联合显微外科IMBR与PMRT联合显微外科DBR的并发症率相似,且避免了TE放置相关并发症并缩短了达到确定性乳房重建的时间。
研究设计与样本
- 随机临床试验(NCT02912312)的二次分析,纳入2018年8月至2022年8月间的乳腺癌患者,随机接受大分割(40.05 Gy/15次)或常规分割(50 Gy/25次)区域淋巴结照射。
- 共纳入144例患者:41例接受Pre-MRT后行乳房切除+IMBR,103例接受PMRT后行DBR(其中66例在乳房切除时放置TE,37例行全乳房切除)。
主要发现
- 两组均无完全自体皮瓣丢失,受区其他并发症率相似。
- PMRT组中放置TE的患者受区感染率为20%(13/66),其中9例(14%)因并发症需取出TE。
- 从乳房切除至DBR的中位时间为12.8个月(四分位距9.7至16.3个月)。
临床怎么用
- 对于需行乳房切除和显微外科乳房重建的患者,Pre-MRT联合IMBR可作为避免TE相关并发症并缩短重建时间的选项。
局限性
- 本研究为随机临床试验的二次分析,样本量有限(共144例),需更大规模随机临床试验(NCT05774678)进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study compared complication rates and outcomes between patients who underwent premastectomy radiation therapy (Pre-MRT) followed by mastectomy with microsurgical immediate breast reconstruction (IMBR) and patients who underwent mastectomy followed by postmastectomy RT (PMRT) then microsurgical delayed breast reconstruction (DBR). STUDY DESIGN: This is a secondary analysis of a randomized clinical trial (NCT02912312) that randomized patients with breast cancer to receive hypofractionated (40.05 Gy in 15 fractions) or conventionally fractionated (50 Gy in 25 fractions) regional nodal irradiation between August 2018 and August 2022. Demographic, treatment, and outcomes data were collected. The primary outcome was the rate of autologous flap loss. Secondary outcomes included rates of other recipient-site complications. RESULTS: A total of 144 patients were included: 41 underwent Pre-MRT with IMBR and 103 underwent PMRT with DBR, including 66 patients who had tissue expander (TE) placement at the time of mastectomy and 37 who underwent total mastectomy. The median time from mastectomy to DBR was 12.8 months (interquartile range 9.7 to 16.3 months). There were no complete autologous flap losses in either group, and rates of other recipient-site complications were similar between the groups. Infection at the recipient site occurred in 20% (13 of 66) of patients in the PMRT group who underwent TE placement, and 9 (14%) required TE explantation because of complications. CONCLUSIONS: Pre-MRT with microvascular IMBR is associated with a similar complication rate to PMRT with microvascular DBR while avoiding complications relating to TE placement and a reduced time to achieve definitive breast reconstruction. A larger randomized clinical trial of Pre-MRT followed by mastectomy and IMBR is currently underway (NCT05774678).
引用
- Schaverien MV, Singh P, Kuerer HM, et al. Comparison of Outcomes of Microsurgical Breast Reconstruction after Premastectomy and Postmastectomy Radiation Therapy. J Am Coll Surg. 2025. PMID: 40366003. doi:10.1097/XCS.0000000000001444
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。